First-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy (TOPICAL): a double-blind, placebo-controlled, phase 3 trial - Concepedia

Concepedia

Publication | Open Access

First-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy (TOPICAL): a double-blind, placebo-controlled, phase 3 trial

DOI Full Paper Access

176

Citations

34

References

2012

Year

Siow Ming Lee, Iftekhar Khan, Sunil Upadhyay, C. Lewanski, Stephen Falk, G. Skailes, Ernie Marshall, Penella J. Woll, M. Hatton, Rohit Lal,

The Lancet Oncology

Abstract

Cancer Research UK, Roche.

References

	Year	Citations

Page 1